Fidelity Investments’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
ACA
VCM
HI
Fidelity Investments's TERN Position: Q1 2026 in Review
Fidelity Investments reduced its Terns Pharmaceuticals (TERN) stake by 71% in Q1 2026, selling an estimated $30M and leaving 295,622 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1873.
Fidelity Investments first reported a position in TERN in Q1 2021 and has held it in 21 quarters since. The position peaked at $90.5M in Q1 2023. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.
- Fidelity Investments held 295,622 shares of Terns Pharmaceuticals worth $15.6M as of Q1 2026.
- Fidelity Investments sold 731,241 Terns Pharmaceuticals shares in Q1 2026, an estimated $30M.
- Terns Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1873 holding.
- Fidelity Investments first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
- Fidelity Investments's Terns Pharmaceuticals position peaked at $90.5M in Q1 2023.
- 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.